Aveanna Healthcare Holdings, Inc. Stock Price, News & Analysis

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) announced it will release its third quarter financial results on November 9, 2022, after market close. A conference call will follow on November 10, 2022, at 10:00 a.m. ET to discuss the results. Investors can join the call by dialing 1-877-407-0789 or access a webcast via the Investor Relations section of Aveanna's website. The replay of the call will be available until November 17, 2022. Aveanna provides a wide range of healthcare services across 33 states, focusing on quality care at lower costs.

Aveanna Healthcare Holdings (NASDAQ: AVAH) reported Q2 2022 revenue of $443 million, up from $436.1 million in Q2 2021, marking a 1.6% increase. However, the company faced significant challenges, including a net loss of $473.9 million compared to a net income of $1.3 million last year, primarily due to a $470.2 million goodwill impairment. Adjusted EBITDA decreased to $37 million, or 8.3% of revenue, down from 11.2% in Q2 2021. Aveanna remains optimistic about future growth opportunities despite ongoing labor market challenges and inflationary wage pressures.

Aveanna Healthcare Holdings (NASDAQ: AVAH) has announced preliminary results for Q2 2022, indicating weaker performance due to ongoing labor market challenges and inflationary wage pressures. The company anticipates Adjusted EBITDA in the range of $36 million to $39 million, significantly lower than prior expectations. Revenue guidance has been revised down to at least $1,785 million, from an earlier estimate of $1,890 million to $1,920 million. Despite these challenges, Aveanna maintains liquidity with $12 million in cash and $167 million available under its revolving credit facility.

Aveanna Healthcare reported a revenue increase of 8.0% to $450.5 million for Q1 2022, driven by acquisitions of Comfort Care and Accredited. Gross margin rose 10.0% to $144.8 million, while net income surged to $25.3 million, bolstered by a $38.3 million non-cash gain on interest rate hedges. However, adjusted EBITDA fell 13.2% to $38.0 million. Operating income decreased 51.3% to $13.8 million, reflecting increased corporate expenses and a decline in field contribution. Aveanna aims to expand services despite ongoing labor and operational challenges.

Aveanna Healthcare Holdings will participate in the RBC Capital Markets Global Healthcare Conference on May 17, 2022. The management team will conduct one-on-one investor meetings and a fireside chat at 11:30 a.m. ET, which interested investors can access via a live webcast on the company's Investor Relations website. Aveanna provides a wide range of healthcare services across 33 states, focusing on both pediatric and adult care, including nursing, rehabilitation, and home health services.

Aveanna Healthcare Holdings (NASDAQ: AVAH) plans to release its first quarter results on May 11, 2022, after market close. The subsequent conference call is scheduled for May 12, 2022, at 10:00 a.m. (ET), where investors can access via phone or online. Aveanna, headquartered in Atlanta, operates in 33 states, providing a range of healthcare services including nursing, rehabilitation, and home health. The company aims to deliver high-quality, cost-effective care alternatives to prolonged hospitalization.

Aveanna Healthcare Holdings, Inc. (NASDAQ: AVAH) announces participation in Arizona's Family Licensed Health Aide Program. This initiative enables eligible family members to receive training and compensation for caregiving at home, addressing the critical nursing shortage. The program is approved by the Arizona State Legislature and signed by Governor Doug Ducey. Aveanna's COO emphasizes the importance of enabling families to balance caregiving and employment. This new program reflects Aveanna's commitment to improving care for medically fragile patients while easing the burden on families.

Aveanna Healthcare Holdings reported a 12.3% increase in fiscal year 2021 revenue to $1,678.6 million despite a net loss of $117.0 million, largely due to a non-cash goodwill impairment. The company achieved a 20.9% increase in Adjusted EBITDA to $184.2 million, with an improved margin. The fourth quarter saw revenue decline 1.9% to $414.1 million, pressured by the Omicron variant impacting workforce recruitment. Aveanna completed key acquisitions and anticipates 2022 revenue guidance of $1,890 to $1,920 million.

Aveanna Healthcare Holdings (NASDAQ: AVAH) announced its participation in two upcoming investor conferences. The first is the Raymond James Institutional Investors Conference on March 8, 2022, at 4:35 p.m. ET in Orlando, Florida.

Following this, the company will engage in a Fireside Chat at the Barclays Global Healthcare Conference on March 15, 2022, at 1:35 p.m. ET in Miami Beach, Florida.

Investors can access a live webcast of the presentations on Aveanna's Investor Relations page, with replays available shortly after.